Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "FR Bordeaux Rossignol R"

From Bioblast
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
{{MiPNetLab
{{O2k-Network Lab
|institution=INSERM-EMI 9929
|institution=INSERM-EMI 9929


Line 7: Line 7:
|city=Bordeaux
|city=Bordeaux
|country=France
|country=France
|Contact=Rossignol Rodrigue
|Contact=Rossignol Rodrigue, Amoedo Nivea D
|MiPNetLab=Bellance Nadege, Jose Caroline
|MiPNetLab=Bellance Nadege, Gutierrez Cortes Nicolas, Jose Caroline, Mazat Jean-Pierre, Saharnaz Sarlak
|Status=O2k 2003-
|Status=[[Power-O2k| '''2 Power-O2k''']] 2003-
|info=[[Bioblast 2012]], [http://oroboros.at/index.php?id=ioc39-schroecken IOC39], [http://oroboros.at/index.php?id=previouscourses IOC23], [http://oroboros.at/index.php?id=previouscourses IOC13]
|info=[[IOC137]], [[MiP2015]], [[MiP2014]], [[MiP2013]], [[Bioblast 2012]], [[IOC72]], [[IOC54]], [[MiPNet12.14 IOC39|IOC39]], [[IOC23]], [[IOC13]]
|Info=[http://www.oroboros.at/index.php?id=1237 FR Bordeaux RossignolR]
|Info=[http://www.oroboros.at/index.php?id=1237 FR Bordeaux RossignolR]
}}
}}
== Bioblast alert ==
::::* [[Bioblast alert 2021]] » [[Amoedo 2021 J Clin Invest]]
[[File:Three musketeers.jpg|right|400px|Rodrigue Rossignol (middle) with Guy Brown (left) and Petr Jezek (right)]]
[[File:Three musketeers.jpg|right|400px|Rodrigue Rossignol (middle) with Guy Brown (left) and Petr Jezek (right)]]

Revision as of 09:33, 15 April 2021

                



FR Bordeaux Rossignol R

Oroboros O2k-Network

O2k-Network
O2k-Network Lab INSERM-EMI 9929

Université Victor Segalen

Address 146, rue Léo Saignat, 33076
City Bordeaux
State/Prov
Country France
Weblink
Contact Rossignol Rodrigue, Amoedo Nivea D
Team Bellance Nadege, Gutierrez Cortes Nicolas, Jose Caroline, Mazat Jean-Pierre, Saharnaz Sarlak
Team previous
Status 2 Power-O2k 2003-
Oroboros Events IOC137, MiP2015, MiP2014, MiP2013, Bioblast 2012, IOC72, IOC54, IOC39, IOC23, IOC13
Topics


O2k-Publications

 PublishedReference
Amoedo 2021 J Clin Invest2021Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, Rousseau B, Dupis A, Izotte J, Bellance N, Dard L, Redonnet-Vernhet I, Punzi G, Rodrigues MF, Dumon E, Mafhouf W, Guyonnet-Dupérat V, Gales L, Palama T, Bellvert F, Dugot-Senan N, Claverol S, Baste JM, Lacombe D, Rezvani HR, Pierri CL, Mechta-Grigoriou F, Thumerel M, Rossignol R (2021) Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. J Clin Invest 131:e133081.
Bastos Sant'Anna Silva 2021 Cancers (Basel)2021Bastos Sant'Anna Silva AC, Perez Valencia JA, Sciacovelli M, Lalou C, Sarlak S, Tronci L, Nikitopoulou E, Meszaros AT, Frezza C, Rossignol R, Gnaiger E, Klocker H (2021) Succinate anaplerosis has an onco-driving potential in prostate cancer cells. https://doi.org/10.3390/cancers13071727
Esteves 2019 Oncogene2019Esteves P, Dard L, Brillac A, Hubert C, Sarlak S, Rousseau B, Dumon E, Izotte J, Bonneu M, Lacombe D, Dupuy JW, Amoedo N, Rossignol R (2019) Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F. Oncogene 39:617-36.
Szelechowski 2018 Sci Rep2018Szelechowski M, Amoedo N, Obre E, Léger C, Allard L, Bonneu M, Claverol S, Lacombe D, Oliet S, Chevallier S, Le Masson G, Rossignol R (2018) Metabolic reprogramming in amyotrophic lateral sclerosis. Sci Rep 8:3953.
Jose 2018 Redox Biol2018Jose C, Hebert-Chatelain E, Dias Amoedo N, Roche E, Obre E, Lacombe D, Rezvani HR, Pourquier P, Nouette-Gaulain K, Rossignol R (2018) Redox mechanism of levobupivacaine cytostatic effect on human prostate cancer cells. Redox Biol 18:33-42.
Rodrigues 2016 Biochem J2015Rodrigues MF, Obre E, Melo FH, Santos-Jr GC, Galina A, Jasiulionis MG, Rossignol R, Rumjanek FD, Amoedo ND (2016) Enhanced OXPHOS, glutaminolysis and beta-oxidation constitute the metastatic phenotype of melanoma cells. https://doi.org/10.1042/BJ20150645
Jose 2012 Thesis2012Jose C (2012) Rôle des mitochondries dans la tumorigénèse: implications pour le traitement du cancer. PhD Thesis 272.
Smolkova 2010 J Bioenerg Biomembr2010Smolková K, Bellance N, Scandurra F, Génot E, Gnaiger E, Plecitá-Hlavatá L, Ježek P, Rossignol R (2010) Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia. https://doi.org/10.1007/s10863-009-9267-x
Bellance 2009 Int J Biochem Cell Biol2009Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: Alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566-77.

O2k-Abstracts

 PublishedReference
Amoedo 2015 Abstract MiP20152015The energy requirement of metastatic cells.
Rodrigues 2014 Abstract MiP20142014Bioenergetics’ traits of tongue cancer metastatic cells.

Bioblast alert

Rodrigue Rossignol (middle) with Guy Brown (left) and Petr Jezek (right)